目的:观察乳腺癌多药耐药细胞MCF-7/ADR中Twist表达及上皮-间质转化现象.探讨其与MCF-7/ADR侵袭转移能力增强的相关性。方法:分别以RT-PCR法、链霉亲和素-生物素酶复合物(Strept avidin biotin complex,SABC)免疫组织化学方法和Western blot法检测乳腺癌细胞系MCF-7及其多药耐药株MCF-7/ADR中介导EMT发生的转录因子Twist、上皮性标记基因E-钙粘素(E—cadherin)和间质性标记基因N-钙粘素(N—cadherin)表达的改变情况。结果:亲本细胞MCF-7中E—cadherin mRNA的表达和蛋白水平的表达均为阳性,Twist和N—cadherin表达阴性;多药耐药株MCF-7/ADR中E—cadherin mRNA和蛋白表达缺失,而在亲本细胞MCF-7中不表达的Twist和N—cadherin表达阳性。结论:在多药耐药乳腺癌细胞MCF-7/ADR中.其侵袭力增强可能与Twist介导的EMT发生有关。
Objective: To study the epithelial to mesenchymal transition and expression level of Twist in MCF-7/ADR multidrug resistant breast cancer cells and to determine the relationship between multidrug resistance (MDR) and metastatic behavior. Methods: RT-PCR, immunohistochemical staining and western blotting were used to detect the changes in expression levels of the transcription factor Twist, E-cadherin and N-cadherin in the breast cancer cell line MCF-7 and its multidrug resistant variant MCF-7/ADR. Results: In MCF-7 cells, the expression of E-cadherin can be detected, but that of Twist and N-cadherin cannot be detected. The expression of E-cadherin in MCF-7/ADR cells was absent and the other two genes were significantly expressed. Conclusions: During the development of MDR, epithelial to mesenchymal transition induced by Twist may be related to the enhanced invasion and metastatic potential of multidrug resistant breast cancer cells MCF-7/ADR.